iOSAT™
received its approval from the US Food and Drug Administration in 1982,
and is the only full-strength tablet for radiation blocking which may
legally be sold in the US. Only iOSAT™ has passed all FDA tests for purity, quality, safety and efficacy.
Meets all FDA requirements
for potassium iodide as a radiation protective, and is labeled and packaged
in accordance with US government guidelines.
Has demonstrated all quality controls and passed all FDA requirements
for purity, quality, safety, efficacy.
Comes full strength (130
mg of potassium iodide per tablet) in accordance with FDA demands for complete
thyroid blocking.
New Dosage Guidelines
An evaluation of the effectiveness of
KI (following its wide use at Chernobyl) has determined that the
product is more effective than originally thought, and that smaller
doses are adequate to achieve thyroid protection in children. This has
led the FDA to issue new guidelines that reduce the amount of KI needed
to achieve the minimally effective dose, as indicated below:
Note that the smaller minimal children's doses reflect the product's
effectiveness, and are only findings that a "half-strength" (or less)
dose will work. There is absolutely no suggestion that the original
full strength dose is harmful, or any reason to doubt the safety or
effectiveness of the original guidelines. Parents need to merely
understand that child protection can be achieved with less KI than
originally thought.
Effective as of 2005, FDA has advised ANBEX that the new guidelines are the ones to be followed.
WARNING: POTASSIUM IODIDE SHOULD NOT BE USED BY PEOPLE ALLERGIC TO IODIDE.
Use only as directed by state or local public health authorities in the
event of a radiation emergency. Store at room temperature. Keep package
dry and foil packets intact.
U.S. Power Reactor
Radiation Zones
Contains no potassium iodate
or other adulterants. Contains only pure potassium iodide as the active
ingredient.
IOSAT [potassium iodide]
Is manufactured in the United States under strict FDA GMP guidelines,
and
holds an approved New Drug Application (NDA).
IOSAT [potassium iodide]
Was the first product of its kind (since 1982) and is the only product that
can be purchased by local, state and federal governments.
Is widely purchased by nuclear utilities.
IOSAT [potassium iodide]
offers unit dose packaging for maximum shelf-life and allows for individual
tablet distribution without fear of loss of packaging integrity.
